- Home
- Labeler Index
- Pacira Pharmaceuticals, Inc.
- 65250-133
- NDC Crossover: 65250-133 Exparel
NDC Crossover 65250-133 Exparel
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Bupivacaine
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 65250-133 – Exparel, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Exparel
- OR Generic name: Bupivacaine
- AND the same Administration Route: infiltration
- OR Dosage Form: injection, suspension, liposomal
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 57884-3251 | Bupivacaine | Bupivacaine | Injection, Suspension, Liposomal | Infiltration | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Human Prescription Drug |
| 57884-3252 | Bupivacaine | Bupivacaine | Injection, Suspension, Liposomal | Infiltration | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Human Prescription Drug |
| 65250-266 | Exparel | Bupivacaine | Injection, Suspension, Liposomal | Infiltration | Pacira Pharmaceuticals, Inc. | Human Prescription Drug |
